AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henry, R. G.
Right arrow Articles by Nelson, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henry, R. G.
Right arrow Articles by Nelson, S. J.

ARTICLE

Comparison of Relative Cerebral Blood Volume and Proton Spectroscopy in Patients with Treated Gliomas

Roland G. Henry,a, Daniel B. Vignerona, Nancy J. Fischbeina, P. Ellen Granta, Mark R. Daya, Susan M. Noworolskia, Joshua M. Star-Lacka, Lawrence L. Walda, William P. Dillona, Susan M. Changa and Sarah J. Nelsona

a From the Departments of Radiology (R.G.H., D.B.V., N.J.F., P.E.G., M.R.D., S.M.N., J.M.S-L., L.L.W., W.P.D., S.J.N.) and Neurosurgery (S.M.C.), University of California at San Francisco; and the Graduate Group in Bioengineering (D.B.V., S.M.N., S.J.N.), University of California, San Francisco and Berkeley.

BACKGROUND AND PURPOSE: Elevated relative regional cerebral blood volume (rCBV) reflects the increased microvascularity that is associated with brain tumors. The purpose of this study was to investigate the potential role of rCBV in the determination of recurrent/residual disease in patients with treated gliomas.

METHODS: Thirty-one rCBV studies were performed in 19 patients with treated gliomas. All patients also had proton MR spectroscopy and conventional MR imaging. Regions of abnormality were identified on conventional MR images by two neuroradiologists and compared with rCBV and MR spectroscopic data. Metabolites and rCBV were quantified and compared in abnormal regions.

RESULTS: In high-grade tumors, rCBV values were proportional to choline in regions of tumor and nonviable tissue. Although the presence of residual/recurrent disease was often ambiguous on conventional MR images, the rCBV maps indicated regions of elevated vascularity in all low-grade tumors and in 12 of 17 grade IV lesions. Regions of elevated and low rCBV corresponded well with spectra, indicating tumor and nonviable tissue, respectively.

CONCLUSION: This study suggests that rCBV maps and MR spectroscopy are complementary techniques that may improve the detection of residual/recurrent tumor in patients with treated gliomas. Compared with the spectra, the rCBV maps may better reflect the heterogeneity of the tumor regions because of their higher resolution. The multiple markers of MR spectroscopy enable better discrimination between normal and abnormal tissue than do the rCBV maps.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, and T. Mikkelsen
Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1981 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Chawla, S. Wang, R.L. Wolf, J.H. Woo, J. Wang, D.M. O'Rourke, K.D. Judy, M.S. Grady, E.R. Melhem, and H. Poptani
Arterial Spin-Labeling and MR Spectroscopy in the Differentiation of Gliomas
AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1683 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J.M. Lupo, S. Cha, S.M. Chang, and S.J. Nelson
Analysis of Metabolic Indices in Regions of Abnormal Perfusion in Patients with High-Grade Glioma
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1455 - 1461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. Ricci, A. Bacci, V. Tugnoli, S. Battaglia, M. Maffei, R. Agati, and M. Leonardi
Metabolic Findings on 3T 1H-MR Spectroscopy in Peritumoral Brain Edema
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1287 - 1291.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. A. Torigian, S. S. Huang, M. Houseni, and A. Alavi
Functional Imaging of Cancer with Emphasis on Molecular Techniques
CA Cancer J Clin, July 1, 2007; 57(4): 206 - 224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. V. Spampinato, J. K. Smith, L. Kwock, M. Ewend, J. D. Grimme, D. L. A. Camacho, and M. Castillo
Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors
Am. J. Roentgenol., January 1, 2007; 188(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. A. Butowski, P. K. Sneed, and S. M. Chang
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
J. Clin. Oncol., March 10, 2006; 24(8): 1273 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Cha
Update on Brain Tumor Imaging: From Anatomy to Physiology
AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 475 - 487.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. M. Lupo, S. Cha, S. M. Chang, and S. J. Nelson
Dynamic Susceptibility-Weighted Perfusion Imaging of High-Grade Gliomas: Characterization of Spatial Heterogeneity
AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
X. Li, D. B. Vigneron, S. Cha, E. E. Graves, F. Crawford, S. M. Chang, and S. J. Nelson
Relationship of MR-Derived Lactate, Mobile Lipids, and Relative Blood Volume for Gliomas in Vivo
AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 760 - 769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale
MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas
AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
D. J. Covarrubias, B. R. Rosen, and M. H. Lev
Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors
Oncologist, September 1, 2004; 9(5): 528 - 537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag
Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Uematsu, M. Maeda, N. Sadato, T. Matsuda, Y. Ishimori, Y. Koshimoto, H. Kimura, H. Yamada, Y. Kawamura, Y. Yonekura, et al.
Blood Volume of Gliomas Determined by Double-Echo Dynamic Perfusion-Weighted MR Imaging: A Preliminary Study
AJNR Am. J. Neuroradiol., November 1, 2001; 22(10): 1915 - 1919.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Law, S. Cha, E. A. Knopp, G. Johnson, J. Arnett, and A. W. Litt
High-Grade Gliomas and Solitary Metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging
Radiology, March 1, 2002; 222(3): 715 - 721.
[Abstract] [Full Text] [PDF]